Flatiron Health

Company profile

About Flatiron Health

Flatiron Health is a leading oncology technology and data company that learns from the experience of every person with cancer to improve outcomes across the entire oncology ecosystem. Founded in 2012 and now an independent affiliate of the Roche Group since 2018, Flatiron operates a global oncology engine built on one of the world's largest oncology datasets spanning the US, UK, Germany, and Japan. The company captures data from millions of cancer patients directly at the source and transforms it into actionable insights through AI-powered intelligence combined with deep oncology expertise. Flatiron serves two primary markets: life sciences organizations across the drug development lifecycle (clinical development, HEOR, market access, regulatory, and commercial teams) and healthcare providers through point-of-care technology used by community oncologists. Their real-world evidence platform has informed over 2,000 peer-reviewed publications and 45+ global regulatory decisions. With datasets exceeding 6 million patient records across the four largest cancer geographies, Flatiron partners with 100% of the top 20 oncology life sciences companies. The company's solutions include Flatiron Real-World Data, Real-World Evidence Insights, and Flatiron Telescope, an AI-powered platform that uses natural language to unlock complex datasets. Their multidisciplinary team includes oncologists, research scientists, data engineers, health equity analysts, and regulatory experts working together to close the gap between cancer care and research.

Company description · Flatiron Health official website

Mission. To improve and extend lives by learning from the experience of every person with cancer.